Riskpilot← Back to searchSign inGet full accessRadeq Nordic AB
ABActiveOrg 5593754525Klinta 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20221 employees
Revenue 2025
SEK 663K
-80% vs 2024
EBITDA margin
17.7%
-84% vs 2024
Equity ratio
89.8%
Financial strength
Net profit 2025
SEK 60K
-89% vs 2024
| Revenue | SEK 663K | -80% |
| EBITDA | SEK 118K | -84% |
| Net profit | SEK 60K | -89% |
| Total assets | SEK 540K | -47% |
| Equity | SEK 485K | -22% |
| Employees | 1 | — |
Legal name
Radeq Nordic AB
Org number
5593754525
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 april 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva handel med utrustning och tillbehör för strålbehandling, konsultationer inom datasäkerhet, mini entreprenad såsom minigrävare och vibbroplog för mindre jobb på tomter och fiberinstallationer samt därmed förenlig verksamhet. Bolaget skall även bedriva konsultverksamhet inom redovisning.
Address
Klinta 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1 131 | 2 926 | 3 338 | 663 |
| Staff expenses | −363 | −1 004 | −574 | −75 |
| EBITDA | 266 | 226 | 739 | 118 |
| Depreciation & amort. | −43 | −91 | −54 | −11 |
| EBIT | 222 | 135 | 686 | 107 |
| Net financials | 0 | −18 | −11 | 2 |
| Profit before tax | 222 | 117 | 674 | 78 |
| Tax | −46 | −26 | −142 | −19 |
| Net profit | 176 | 91 | 533 | 60 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 354 | 1 067 | 1 019 | 540 |
| Equity | 201 | 293 | 625 | 485 |
| Long-term debt | — | 128 | 0 | — |
| Short-term debt | 152 | 647 | 393 | 25 |
| Total debt | 152 | 775 | 393 | 25 |
EBITDA margin
17.7%
This company
15.8%
Market median
+12% vs market
20222025
Equity ratio
89.8%
This company
38.2%
Market median
+135% vs market
20222025
Return on equity
12.3%
This company
18.4%
Market median
+33% vs market
20222025
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20222025
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
20222025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-04-11 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Radeq Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Milton Noah Myhrberg | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Elsa Beatrice Carin Linnea Palm | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |